APO Research
Talk to an analyst

APO RESEARCH · REPORT

Gusperimus

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Gusperimus Market Analysis and Forecast 2026-2032

22 December 2025197 pages

Choose your research edition.

Industry ResearchGusperimus Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Gusperimus Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Gusperimus Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Gusperimus Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Gusperimus Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Gusperimus market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Gusperimus is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Gusperimus is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Gusperimus is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Gusperimus is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Gusperimus include Fine Chem Trading LTD, Dideu Industries, Nihon Kayaku Kabushiki-gaisha, AK Scientific, Inc., A2B Chem LLC, Service Chemical Inc., Ecochem International Chemical Broker and Bristol-Myers Squibb, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Gusperimus, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Gusperimus, also provides the sales of main regions and countries. Of the upcoming market potential for Gusperimus, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Gusperimus sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Gusperimus market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Gusperimus sales, projected growth trends, production technology, application and end-user industry.

Gusperimus Segment by Company

Fine Chem Trading LTD

Dideu Industries

Nihon Kayaku Kabushiki-gaisha

AK Scientific, Inc.

A2B Chem LLC

Service Chemical Inc.

Ecochem International Chemical Broker

Bristol-Myers Squibb

Gusperimus Segment by Type

10mg

20mg

50mg

100mg

Gusperimus Segment by Application

Granulomatous Polyangiitis

Rheumatoid Arthritis

Crohn's Disease

Anti-graft Rejection

Amyotrophic Lateral Sclerosis

Lupus Erythematosus

Gusperimus Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Gusperimus market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Gusperimus and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Gusperimus.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Gusperimus in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Gusperimus manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Gusperimus sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Gusperimus Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 10mg Major Manufacturers Table 3. 20mg Major Manufacturers Table 4. 50mg Major Manufacturers Table 5. 100mg Major Manufacturers Table 6. Global Gusperimus Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Granulomatous Polyangiitis Major Manufacturers Table 8. Rheumatoid Arthritis Major Manufacturers Table 9. Crohn's Disease Major Manufacturers Table 10. Anti-graft Rejection Major Manufacturers Table 11. Amyotrophic Lateral Sclerosis Major Manufacturers Table 12. Lupus Erythematosus Major Manufacturers Table 13. Gusperimus Industry Trends Table 14. Gusperimus Industry Drivers Table 15. Gusperimus Industry Opportunities and Challenges Table 16. Gusperimus Industry Restraints Table 17. Global Gusperimus Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 18. Global Gusperimus Revenue by Region (2021-2026) & (US$ Million) Table 19. Global Gusperimus Revenue by Region (2027-2032) & (US$ Million) Table 20. Global Gusperimus Revenue Market Share by Region (2021-2026) Table 21. Global Gusperimus Revenue Market Share by Region (2027-2032) Table 22. Global Gusperimus Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 23. Global Gusperimus Sales by Region (2021-2026) & (k units) Table 24. Global Gusperimus Sales by Region (2027-2032) & (k units) Table 25. Global Gusperimus Sales Market Share by Region (2021-2026) Table 26. Global Gusperimus Sales Market Share by Region (2027-2032) Table 27. Global Gusperimus Revenue by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Gusperimus Revenue Market Share by Manufacturers (2021-2026) Table 29. Global Gusperimus Sales by Manufacturers (US$ Million) & (2021-2026) Table 30. Global Gusperimus Sales Market Share by Manufacturers (2021-2026) Table 31. Global Gusperimus Sales Price (US$/unit) of Manufacturers (2021-2026) Table 32. Global Gusperimus Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 33. Global Gusperimus Key Manufacturers Manufacturing Sites & Headquarters Table 34. Global Gusperimus Manufacturers, Product Type & Application Table 35. Global Gusperimus Manufacturers' Establishment Date Table 36. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 37. Global Gusperimus by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 38. Global Gusperimus Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Gusperimus Revenue by Type (2021-2026) & (US$ Million) Table 40. Global Gusperimus Revenue by Type (2027-2032) & (US$ Million) Table 41. Global Gusperimus Revenue Market Share by Type (2021-2026) Table 42. Global Gusperimus Revenue Market Share by Type (2027-2032) Table 43. Global Gusperimus Sales by Type 2021 VS 2025 VS 2032 (k units) Table 44. Global Gusperimus Sales by Type (2021-2026) & (k units) Table 45. Global Gusperimus Sales by Type (2027-2032) & (k units) Table 46. Global Gusperimus Sales Market Share by Type (2021-2026) Table 47. Global Gusperimus Sales Market Share by Type (2027-2032) Table 48. Global Gusperimus Price by Type (2021-2026) & (US$/unit) Table 49. Global Gusperimus Price by Type (2027-2032) & (US$/unit) Table 50. Global Gusperimus Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 51. Global Gusperimus Revenue by Application (2021-2026) & (US$ Million) Table 52. Global Gusperimus Revenue by Application (2027-2032) & (US$ Million) Table 53. Global Gusperimus Revenue Market Share by Application (2021-2026) Table 54. Global Gusperimus Revenue Market Share by Application (2027-2032) Table 55. Global Gusperimus Sales by Application 2021 VS 2025 VS 2032 (k units) Table 56. Global Gusperimus Sales by Application (2021-2026) & (k units) Table 57. Global Gusperimus Sales by Application (2027-2032) & (k units) Table 58. Global Gusperimus Sales Market Share by Application (2021-2026) Table 59. Global Gusperimus Sales Market Share by Application (2027-2032) Table 60. Global Gusperimus Price by Application (2021-2026) & (US$/unit) Table 61. Global Gusperimus Price by Application (2027-2032) & (US$/unit) Table 62. Fine Chem Trading LTD Company Information Table 63. Fine Chem Trading LTD Business Overview Table 64. Fine Chem Trading LTD Gusperimus Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Fine Chem Trading LTD Gusperimus Product Portfolio Table 66. Fine Chem Trading LTD Recent Development Table 67. Dideu Industries Company Information Table 68. Dideu Industries Business Overview Table 69. Dideu Industries Gusperimus Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Dideu Industries Gusperimus Product Portfolio Table 71. Dideu Industries Recent Development Table 72. Nihon Kayaku Kabushiki-gaisha Company Information Table 73. Nihon Kayaku Kabushiki-gaisha Business Overview Table 74. Nihon Kayaku Kabushiki-gaisha Gusperimus Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Nihon Kayaku Kabushiki-gaisha Gusperimus Product Portfolio Table 76. Nihon Kayaku Kabushiki-gaisha Recent Development Table 77. AK Scientific, Inc. Company Information Table 78. AK Scientific, Inc. Business Overview Table 79. AK Scientific, Inc. Gusperimus Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. AK Scientific, Inc. Gusperimus Product Portfolio Table 81. AK Scientific, Inc. Recent Development Table 82. A2B Chem LLC Company Information Table 83. A2B Chem LLC Business Overview Table 84. A2B Chem LLC Gusperimus Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. A2B Chem LLC Gusperimus Product Portfolio Table 86. A2B Chem LLC Recent Development Table 87. Service Chemical Inc. Company Information Table 88. Service Chemical Inc. Business Overview Table 89. Service Chemical Inc. Gusperimus Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Service Chemical Inc. Gusperimus Product Portfolio Table 91. Service Chemical Inc. Recent Development Table 92. Ecochem International Chemical Broker Company Information Table 93. Ecochem International Chemical Broker Business Overview Table 94. Ecochem International Chemical Broker Gusperimus Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Ecochem International Chemical Broker Gusperimus Product Portfolio Table 96. Ecochem International Chemical Broker Recent Development Table 97. Bristol-Myers Squibb Company Information Table 98. Bristol-Myers Squibb Business Overview Table 99. Bristol-Myers Squibb Gusperimus Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Bristol-Myers Squibb Gusperimus Product Portfolio Table 101. Bristol-Myers Squibb Recent Development Table 102. North America Gusperimus Revenue by Type (2021-2026) & (US$ Million) Table 103. North America Gusperimus Revenue by Type (2027-2032) & (US$ Million) Table 104. North America Gusperimus Sales by Type (2021-2026) & (k units) Table 105. North America Gusperimus Sales by Type (2027-2032) & (k units) Table 106. North America Gusperimus Sales Price by Type (2021-2026) & (US$/unit) Table 107. North America Gusperimus Sales Price by Type (2027-2032) & (US$/unit) Table 108. North America Gusperimus Revenue by Application (2021-2026) & (US$ Million) Table 109. North America Gusperimus Revenue by Application (2027-2032) & (US$ Million) Table 110. North America Gusperimus Sales by Application (2021-2026) & (k units) Table 111. North America Gusperimus Sales by Application (2027-2032) & (k units) Table 112. North America Gusperimus Sales Price by Application (2021-2026) & (US$/unit) Table 113. North America Gusperimus Sales Price by Application (2027-2032) & (US$/unit) Table 114. North America Gusperimus Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. North America Gusperimus Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 116. North America Gusperimus Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 117. North America Gusperimus Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 118. North America Gusperimus Sales by Country (2021-2026) & (k units) Table 119. North America Gusperimus Sales by Country (2027-2032) & (k units) Table 120. North America Gusperimus Sales Price by Country (2021-2026) & (US$/unit) Table 121. North America Gusperimus Sales Price by Country (2027-2032) & (US$/unit) Table 122. United States Gusperimus Revenue (2021-2032) & (US$ Million) Table 123. Canada Gusperimus Revenue (2021-2032) & (US$ Million) Table 124. Mexico Gusperimus Revenue (2021-2032) & (US$ Million) Table 125. Europe Gusperimus Revenue by Type (2021-2026) & (US$ Million) Table 126. Europe Gusperimus Revenue by Type (2027-2032) & (US$ Million) Table 127. Europe Gusperimus Sales by Type (2021-2026) & (k units) Table 128. Europe Gusperimus Sales by Type (2027-2032) & (k units) Table 129. Europe Gusperimus Sales Price by Type (2021-2026) & (US$/unit) Table 130. Europe Gusperimus Sales Price by Type (2027-2032) & (US$/unit) Table 131. Europe Gusperimus Revenue by Application (2021-2026) & (US$ Million) Table 132. Europe Gusperimus Revenue by Application (2027-2032) & (US$ Million) Table 133. Europe Gusperimus Sales by Application (2021-2026) & (k units) Table 134. Europe Gusperimus Sales by Application (2027-2032) & (k units) Table 135. Europe Gusperimus Sales Price by Application (2021-2026) & (US$/unit) Table 136. Europe Gusperimus Sales Price by Application (2027-2032) & (US$/unit) Table 137. Europe Gusperimus Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. Europe Gusperimus Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 139. Europe Gusperimus Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 140. Europe Gusperimus Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 141. Europe Gusperimus Sales by Country (2021-2026) & (k units) Table 142. Europe Gusperimus Sales by Country (2027-2032) & (k units) Table 143. Europe Gusperimus Sales Price by Country (2021-2026) & (US$/unit) Table 144. Europe Gusperimus Sales Price by Country (2027-2032) & (US$/unit) Table 145. Germany Gusperimus Revenue (2021-2032) & (US$ Million) Table 146. France Gusperimus Revenue (2021-2032) & (US$ Million) Table 147. U.K. Gusperimus Revenue (2021-2032) & (US$ Million) Table 148. Italy Gusperimus Revenue (2021-2032) & (US$ Million) Table 149. Russia Gusperimus Revenue (2021-2032) & (US$ Million) Table 150. Spain Gusperimus Revenue (2021-2032) & (US$ Million) Table 151. Netherlands Gusperimus Revenue (2021-2032) & (US$ Million) Table 152. Switzerland Gusperimus Revenue (2021-2032) & (US$ Million) Table 153. Sweden Gusperimus Revenue (2021-2032) & (US$ Million) Table 154. Poland Gusperimus Revenue (2021-2032) & (US$ Million) Table 155. China Gusperimus Revenue by Type (2021-2026) & (US$ Million) Table 156. China Gusperimus Revenue by Type (2027-2032) & (US$ Million) Table 157. China Gusperimus Sales by Type (2021-2026) & (k units) Table 158. China Gusperimus Sales by Type (2027-2032) & (k units) Table 159. China Gusperimus Sales Price by Type (2021-2026) & (US$/unit) Table 160. China Gusperimus Sales Price by Type (2027-2032) & (US$/unit) Table 161. China Gusperimus Revenue by Application (2021-2026) & (US$ Million) Table 162. China Gusperimus Revenue by Application (2027-2032) & (US$ Million) Table 163. China Gusperimus Sales by Application (2021-2026) & (k units) Table 164. China Gusperimus Sales by Application (2027-2032) & (k units) Table 165. China Gusperimus Sales Price by Application (2021-2026) & (US$/unit) Table 166. China Gusperimus Sales Price by Application (2027-2032) & (US$/unit) Table 167. Asia Gusperimus Revenue by Type (2021-2026) & (US$ Million) Table 168. Asia Gusperimus Revenue by Type (2027-2032) & (US$ Million) Table 169. Asia Gusperimus Sales by Type (2021-2026) & (k units) Table 170. Asia Gusperimus Sales by Type (2027-2032) & (k units) Table 171. Asia Gusperimus Sales Price by Type (2021-2026) & (US$/unit) Table 172. Asia Gusperimus Sales Price by Type (2027-2032) & (US$/unit) Table 173. Asia Gusperimus Revenue by Application (2021-2026) & (US$ Million) Table 174. Asia Gusperimus Revenue by Application (2027-2032) & (US$ Million) Table 175. Asia Gusperimus Sales by Application (2021-2026) & (k units) Table 176. Asia Gusperimus Sales by Application (2027-2032) & (k units) Table 177. Asia Gusperimus Sales Price by Application (2021-2026) & (US$/unit) Table 178. Asia Gusperimus Sales Price by Application (2027-2032) & (US$/unit) Table 179. Asia Gusperimus Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 180. Asia Gusperimus Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 181. Asia Gusperimus Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 182. Asia Gusperimus Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 183. Asia Gusperimus Sales by Country (2021-2026) & (k units) Table 184. Asia Gusperimus Sales by Country (2027-2032) & (k units) Table 185. Asia Gusperimus Sales Price by Country (2021-2026) & (US$/unit) Table 186. Asia Gusperimus Sales Price by Country (2027-2032) & (US$/unit) Table 187. Japan Gusperimus Revenue (2021-2032) & (US$ Million) Table 188. South Korea Gusperimus Revenue (2021-2032) & (US$ Million) Table 189. India Gusperimus Revenue (2021-2032) & (US$ Million) Table 190. Australia Gusperimus Revenue (2021-2032) & (US$ Million) Table 191. Taiwan Gusperimus Revenue (2021-2032) & (US$ Million) Table 192. Southeast Asia Gusperimus Revenue (2021-2032) & (US$ Million) Table 193. SAMEA Gusperimus Revenue by Type (2021-2026) & (US$ Million) Table 194. SAMEA Gusperimus Revenue by Type (2027-2032) & (US$ Million) Table 195. SAMEA Gusperimus Sales by Type (2021-2026) & (k units) Table 196. SAMEA Gusperimus Sales by Type (2027-2032) & (k units) Table 197. SAMEA Gusperimus Sales Price by Type (2021-2026) & (US$/unit) Table 198. SAMEA Gusperimus Sales Price by Type (2027-2032) & (US$/unit) Table 199. SAMEA Gusperimus Revenue by Application (2021-2026) & (US$ Million) Table 200. SAMEA Gusperimus Revenue by Application (2027-2032) & (US$ Million) Table 201. SAMEA Gusperimus Sales by Application (2021-2026) & (k units) Table 202. SAMEA Gusperimus Sales by Application (2027-2032) & (k units) Table 203. SAMEA Gusperimus Sales Price by Application (2021-2026) & (US$/unit) Table 204. SAMEA Gusperimus Sales Price by Application (2027-2032) & (US$/unit) Table 205. SAMEA Gusperimus Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 206. SAMEA Gusperimus Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 207. SAMEA Gusperimus Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 208. SAMEA Gusperimus Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 209. SAMEA Gusperimus Sales by Country (2021-2026) & (k units) Table 210. SAMEA Gusperimus Sales by Country (2027-2032) & (k units) Table 211. SAMEA Gusperimus Sales Price by Country (2021-2026) & (US$/unit) Table 212. SAMEA Gusperimus Sales Price by Country (2027-2032) & (US$/unit) Table 213. Brazil Gusperimus Revenue (2021-2032) & (US$ Million) Table 214. Argentina Gusperimus Revenue (2021-2032) & (US$ Million) Table 215. Chile Gusperimus Revenue (2021-2032) & (US$ Million) Table 216. Colombia Gusperimus Revenue (2021-2032) & (US$ Million) Table 217. Peru Gusperimus Revenue (2021-2032) & (US$ Million) Table 218. Saudi Arabia Gusperimus Revenue (2021-2032) & (US$ Million) Table 219. Israel Gusperimus Revenue (2021-2032) & (US$ Million) Table 220. UAE Gusperimus Revenue (2021-2032) & (US$ Million) Table 221. Turkey Gusperimus Revenue (2021-2032) & (US$ Million) Table 222. Iran Gusperimus Revenue (2021-2032) & (US$ Million) Table 223. Egypt Gusperimus Revenue (2021-2032) & (US$ Million) Table 224. Key Raw Materials Table 225. Raw Materials Key Suppliers Table 226. Gusperimus Distributors List Table 227. Gusperimus Customers List Table 228. Research Programs/Design for This Report Table 229. Authors List of This Report Table 230. Secondary Sources Table 231. Primary Sources List of Figures Figure 1. Gusperimus Image Figure 2. Global Gusperimus Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Gusperimus Market Size Share 2021 VS 2025 VS 2032 Figure 4. 10mg Image Figure 5. 20mg Image Figure 6. 50mg Image Figure 7. 100mg Image Figure 8. Global Gusperimus Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Gusperimus Market Size Share 2021 VS 2025 VS 2032 Figure 10. Granulomatous Polyangiitis Image Figure 11. Rheumatoid Arthritis Image Figure 12. Crohn's Disease Image Figure 13. Anti-graft Rejection Image Figure 14. Amyotrophic Lateral Sclerosis Image Figure 15. Lupus Erythematosus Image Figure 16. Global Gusperimus Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 17. Global Gusperimus Revenue (2021-2032) & (US$ Million) Figure 18. Global Gusperimus Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Gusperimus Revenue Market Share by Region: 2025 Versus 2032 Figure 20. Global Gusperimus Revenue Market Share by Region (2021-2032) Figure 21. Global Gusperimus Sales (2021-2032) & (k units) Figure 22. Global Gusperimus Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 23. Global Gusperimus Sales Market Share by Region (2021-2032) Figure 24. US & Canada & Mexico Gusperimus Sales YoY (2021-2032) & (k units) Figure 25. Europe Gusperimus Sales YoY (2021-2032) & (k units) Figure 26. China Gusperimus Sales YoY (2021-2032) & (k units) Figure 27. Asia (Excluding China) Gusperimus Sales YoY (2021-2032) & (k units) Figure 28. South America, Middle East and Africa Gusperimus Sales YoY (2021-2032) & (k units) Figure 29. Global Gusperimus Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 30. Global Gusperimus Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 31. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 32. Global Gusperimus Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 33. Global Gusperimus Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Gusperimus Revenue Market Share by Type (2021-2032) Figure 35. Global Gusperimus Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 36. Global Gusperimus Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 37. Global Gusperimus Sales Market Share by Type (2021-2032) Figure 38. Global Gusperimus Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 39. Global Gusperimus Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Gusperimus Revenue Market Share by Application (2021-2032) Figure 41. Global Gusperimus Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 42. Global Gusperimus Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 43. Global Gusperimus Sales Market Share by Application (2021-2032) Figure 44. North America Gusperimus Revenue Share by Type (2021-2032) Figure 45. North America Gusperimus Sales Share by Type (2021-2032) Figure 46. North America Gusperimus Revenue Share by Application (2021-2032) Figure 47. North America Gusperimus Sales Share by Application (2021-2032) Figure 48. North America Gusperimus Revenue Share by Country (2021-2032) Figure 49. North America Gusperimus Sales Share by Country (2021-2032) Figure 50. Europe Gusperimus Revenue Share by Type (2021-2032) Figure 51. Europe Gusperimus Sales Share by Type (2021-2032) Figure 52. Europe Gusperimus Revenue Share by Application (2021-2032) Figure 53. Europe Gusperimus Sales Share by Application (2021-2032) Figure 54. Europe Gusperimus Revenue Share by Country (2021-2032) Figure 55. Europe Gusperimus Sales Share by Country (2021-2032) Figure 56. China Gusperimus Revenue Share by Type (2021-2032) Figure 57. China Gusperimus Sales Share by Type (2021-2032) Figure 58. China Gusperimus Revenue Share by Application (2021-2032) Figure 59. China Gusperimus Sales Share by Application (2021-2032) Figure 60. Asia Gusperimus Revenue Share by Type (2021-2032) Figure 61. Asia Gusperimus Sales Share by Type (2021-2032) Figure 62. Asia Gusperimus Revenue Share by Application (2021-2032) Figure 63. Asia Gusperimus Sales Share by Application (2021-2032) Figure 64. Asia Gusperimus Revenue Share by Country (2021-2032) Figure 65. Asia Gusperimus Sales Share by Country (2021-2032) Figure 66. SAMEA Gusperimus Revenue Share by Type (2021-2032) Figure 67. SAMEA Gusperimus Sales Share by Type (2021-2032) Figure 68. SAMEA Gusperimus Revenue Share by Application (2021-2032) Figure 69. SAMEA Gusperimus Sales Share by Application (2021-2032) Figure 70. SAMEA Gusperimus Revenue Share by Country (2021-2032) Figure 71. SAMEA Gusperimus Sales Share by Country (2021-2032) Figure 72. Gusperimus Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Gusperimus Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg
  • 20mg
  • 50mg
  • 100mg
Applications
  • Granulomatous Polyangiitis
  • Rheumatoid Arthritis
  • Crohn's Disease
  • Anti-graft Rejection
  • Amyotrophic Lateral Sclerosis
  • Lupus Erythematosus
Companies covered
  • Fine Chem Trading LTD
  • Dideu Industries
  • Nihon Kayaku Kabushiki-gaisha
  • AK Scientific, Inc.
  • A2B Chem LLC
  • Service Chemical Inc.
  • Ecochem International Chemical Broker
  • Bristol-Myers Squibb

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Gusperimus Market by Type
  3. 1.2.1 Global Gusperimus Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 10mg
  5. 1.2.3 20mg
  6. 1.2.4 50mg
  7. 1.2.5 100mg
  8. 1.3 Gusperimus Market by Application
  9. 1.3.1 Global Gusperimus Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Granulomatous Polyangiitis
  11. 1.3.3 Rheumatoid Arthritis
  12. 1.3.4 Crohn's Disease
  13. 1.3.5 Anti-graft Rejection
  14. 1.3.6 Amyotrophic Lateral Sclerosis
  15. 1.3.7 Lupus Erythematosus
  16. 1.4 Assumptions and Limitations
  17. 1.5 Study Goals and Objectives
2 Gusperimus Market Dynamics
  1. 2.1 Gusperimus Industry Trends
  2. 2.2 Gusperimus Industry Drivers
  3. 2.3 Gusperimus Industry Opportunities and Challenges
  4. 2.4 Gusperimus Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Gusperimus Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Gusperimus Revenue by Region
  3. 3.2.1 Global Gusperimus Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Gusperimus Revenue by Region (2021-2026)
  5. 3.2.3 Global Gusperimus Revenue by Region (2027-2032)
  6. 3.2.4 Global Gusperimus Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Gusperimus Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Gusperimus Sales by Region
  9. 3.4.1 Global Gusperimus Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Gusperimus Sales by Region (2021-2026)
  11. 3.4.3 Global Gusperimus Sales by Region (2027-2032)
  12. 3.4.4 Global Gusperimus Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Gusperimus Revenue by Manufacturers
  2. 4.1.1 Global Gusperimus Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Gusperimus Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Gusperimus Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Gusperimus Sales by Manufacturers
  6. 4.2.1 Global Gusperimus Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Gusperimus Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Gusperimus Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Gusperimus Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Gusperimus Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Gusperimus Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Gusperimus Manufacturers, Product Type & Application
  13. 4.7 Global Gusperimus Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Gusperimus Market CR5 and HHI
  16. 4.8.2 2025 Gusperimus Tier 1, Tier 2, and Tier 3
5 Gusperimus Market by Type
  1. 5.1 Global Gusperimus Revenue by Type
  2. 5.1.1 Global Gusperimus Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Gusperimus Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Gusperimus Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Gusperimus Sales by Type
  6. 5.2.1 Global Gusperimus Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Gusperimus Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Gusperimus Sales Market Share by Type (2021-2032)
  9. 5.3 Global Gusperimus Price by Type
6 Gusperimus Market by Application
  1. 6.1 Global Gusperimus Revenue by Application
  2. 6.1.1 Global Gusperimus Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Gusperimus Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Gusperimus Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Gusperimus Sales by Application
  6. 6.2.1 Global Gusperimus Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Gusperimus Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Gusperimus Sales Market Share by Application (2021-2032)
  9. 6.3 Global Gusperimus Price by Application
7 Company Profiles
  1. 7.1 Fine Chem Trading LTD
  2. 7.1.1 Fine Chem Trading LTD Company Information
  3. 7.1.2 Fine Chem Trading LTD Business Overview
  4. 7.1.3 Fine Chem Trading LTD Gusperimus Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Fine Chem Trading LTD Gusperimus Product Portfolio
  6. 7.1.5 Fine Chem Trading LTD Recent Developments
  7. 7.2 Dideu Industries
  8. 7.2.1 Dideu Industries Company Information
  9. 7.2.2 Dideu Industries Business Overview
  10. 7.2.3 Dideu Industries Gusperimus Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Dideu Industries Gusperimus Product Portfolio
  12. 7.2.5 Dideu Industries Recent Developments
  13. 7.3 Nihon Kayaku Kabushiki-gaisha
  14. 7.3.1 Nihon Kayaku Kabushiki-gaisha Company Information
  15. 7.3.2 Nihon Kayaku Kabushiki-gaisha Business Overview
  16. 7.3.3 Nihon Kayaku Kabushiki-gaisha Gusperimus Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Nihon Kayaku Kabushiki-gaisha Gusperimus Product Portfolio
  18. 7.3.5 Nihon Kayaku Kabushiki-gaisha Recent Developments
  19. 7.4 AK Scientific, Inc.
  20. 7.4.1 AK Scientific, Inc. Company Information
  21. 7.4.2 AK Scientific, Inc. Business Overview
  22. 7.4.3 AK Scientific, Inc. Gusperimus Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 AK Scientific, Inc. Gusperimus Product Portfolio
  24. 7.4.5 AK Scientific, Inc. Recent Developments
  25. 7.5 A2B Chem LLC
  26. 7.5.1 A2B Chem LLC Company Information
  27. 7.5.2 A2B Chem LLC Business Overview
  28. 7.5.3 A2B Chem LLC Gusperimus Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 A2B Chem LLC Gusperimus Product Portfolio
  30. 7.5.5 A2B Chem LLC Recent Developments
  31. 7.6 Service Chemical Inc.
  32. 7.6.1 Service Chemical Inc. Company Information
  33. 7.6.2 Service Chemical Inc. Business Overview
  34. 7.6.3 Service Chemical Inc. Gusperimus Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Service Chemical Inc. Gusperimus Product Portfolio
  36. 7.6.5 Service Chemical Inc. Recent Developments
  37. 7.7 Ecochem International Chemical Broker
  38. 7.7.1 Ecochem International Chemical Broker Company Information
  39. 7.7.2 Ecochem International Chemical Broker Business Overview
  40. 7.7.3 Ecochem International Chemical Broker Gusperimus Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Ecochem International Chemical Broker Gusperimus Product Portfolio
  42. 7.7.5 Ecochem International Chemical Broker Recent Developments
  43. 7.8 Bristol-Myers Squibb
  44. 7.8.1 Bristol-Myers Squibb Company Information
  45. 7.8.2 Bristol-Myers Squibb Business Overview
  46. 7.8.3 Bristol-Myers Squibb Gusperimus Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Bristol-Myers Squibb Gusperimus Product Portfolio
  48. 7.8.5 Bristol-Myers Squibb Recent Developments
8 North America
  1. 8.1 North America Gusperimus Market Size by Type
  2. 8.1.1 North America Gusperimus Revenue by Type (2021-2032)
  3. 8.1.2 North America Gusperimus Sales by Type (2021-2032)
  4. 8.1.3 North America Gusperimus Price by Type (2021-2032)
  5. 8.2 North America Gusperimus Market Size by Application
  6. 8.2.1 North America Gusperimus Revenue by Application (2021-2032)
  7. 8.2.2 North America Gusperimus Sales by Application (2021-2032)
  8. 8.2.3 North America Gusperimus Price by Application (2021-2032)
  9. 8.3 North America Gusperimus Market Size by Country
  10. 8.3.1 North America Gusperimus Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Gusperimus Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Gusperimus Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Gusperimus Market Size by Type
  2. 9.1.1 Europe Gusperimus Revenue by Type (2021-2032)
  3. 9.1.2 Europe Gusperimus Sales by Type (2021-2032)
  4. 9.1.3 Europe Gusperimus Price by Type (2021-2032)
  5. 9.2 Europe Gusperimus Market Size by Application
  6. 9.2.1 Europe Gusperimus Revenue by Application (2021-2032)
  7. 9.2.2 Europe Gusperimus Sales by Application (2021-2032)
  8. 9.2.3 Europe Gusperimus Price by Application (2021-2032)
  9. 9.3 Europe Gusperimus Market Size by Country
  10. 9.3.1 Europe Gusperimus Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Gusperimus Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Gusperimus Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Gusperimus Market Size by Type
  2. 10.1.1 China Gusperimus Revenue by Type (2021-2032)
  3. 10.1.2 China Gusperimus Sales by Type (2021-2032)
  4. 10.1.3 China Gusperimus Price by Type (2021-2032)
  5. 10.2 China Gusperimus Market Size by Application
  6. 10.2.1 China Gusperimus Revenue by Application (2021-2032)
  7. 10.2.2 China Gusperimus Sales by Application (2021-2032)
  8. 10.2.3 China Gusperimus Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Gusperimus Market Size by Type
  2. 11.1.1 Asia Gusperimus Revenue by Type (2021-2032)
  3. 11.1.2 Asia Gusperimus Sales by Type (2021-2032)
  4. 11.1.3 Asia Gusperimus Price by Type (2021-2032)
  5. 11.2 Asia Gusperimus Market Size by Application
  6. 11.2.1 Asia Gusperimus Revenue by Application (2021-2032)
  7. 11.2.2 Asia Gusperimus Sales by Application (2021-2032)
  8. 11.2.3 Asia Gusperimus Price by Application (2021-2032)
  9. 11.3 Asia Gusperimus Market Size by Country
  10. 11.3.1 Asia Gusperimus Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Gusperimus Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Gusperimus Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Gusperimus Market Size by Type
  2. 12.1.1 SAMEA Gusperimus Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Gusperimus Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Gusperimus Price by Type (2021-2032)
  5. 12.2 SAMEA Gusperimus Market Size by Application
  6. 12.2.1 SAMEA Gusperimus Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Gusperimus Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Gusperimus Price by Application (2021-2032)
  9. 12.3 SAMEA Gusperimus Market Size by Country
  10. 12.3.1 SAMEA Gusperimus Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Gusperimus Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Gusperimus Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Gusperimus Value Chain Analysis
  2. 13.1.1 Gusperimus Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Gusperimus Production Mode & Process
  6. 13.2 Gusperimus Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Gusperimus Distributors
  9. 13.2.3 Gusperimus Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst